文献速递消化道肿瘤与早癌

胆汁酸诱导胃黏膜肠上皮化生中miR-92a-1-5p通过靶向FOXD1上调CDX2

MicroRNA-92a-1-5p increases CDX2 by targeting FOXD1 in bile acids-induced gastric intestinal metaplasia.
PubMed 文献 · Gut · 2019-01-11

研究通过微阵列分析胆汁酸处理细胞的miRNA/mRNA谱,发现胆汁酸上调miR-92a-1-5p并抑制其靶基因FOXD1。miR-92a-1-5p通过靶向FOXD1/FOXJ1轴及调控NF-κB通路激活CDX2及下游肠道标志物,且肠上皮化生组织中高miR-92a-1-5p与低FOXD1、高CDX2相关。

要点

  • 胆汁酸诱导胃细胞中miR-92a-1-5p上调并抑制FOXD1。
  • miR-92a-1-5p通过FOXD1/FOXJ1轴及NF-κB通路激活CDX2。
  • 肠上皮化生组织中高miR-92a-1-5p与低FOXD1、高CDX2相关。

核心结论

  • miR-92a-1-5p/FOXD1/NF-κB/CDX2调控轴在胃细胞向肠上皮化生表型转化中起关键作用。
  • 抑制miR-92a-1-5p和恢复FOXD1可能是胆汁反流患者胃黏膜肠上皮化生的预防方法。

研究设计与样本

  • 使用微阵列对胆汁酸处理细胞进行miRNA和mRNA谱分析,整合基因本体(GO)分析和生物信息学检测潜在调控回路。
  • 转染胃癌细胞系以评估miRNA模拟物和抑制剂对候选靶基因表达及功能的影响。
  • 采用免疫组化和原位杂交检测肠上皮化生组织微阵列中选定miRNA及其靶标的表达。

主要发现

  • 发现胆汁酸触发胃细胞中miR-92a-1-5p上调并抑制其靶标FOXD1的通路。
  • miR-92a-1-5p在肠上皮化生组织中增加并由胆汁酸诱导。
  • miR-92a-1-5p通过靶向FOXD1/FOXJ1轴和调节核因子κB(NF-κB)通路激活CDX2及下游肠道标志物。
  • 肠上皮化生组织中高miR-92a-1-5p水平与低FOXD1水平和高CDX2水平相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Gastric intestinal metaplasia (IM) is common in the gastric epithelium of patients with chronic atrophic gastritis. CDX2 activation in IM is driven by reflux of bile acids and following chronic inflammation. But the mechanism underlying how bile acids activate CDX2 in gastric epithelium has not been fully explored. METHODS: We performed microRNA (miRNA) and messenger RNA (mRNA) profiling using microarray in cells treated with bile acids. Data integration of the miRNA/mRNA profiles with gene ontology (GO) analysis and bioinformatics was performed to detect potential miRNA-mRNA regulatory circuits. Transfection of gastric cancer cell lines with miRNA mimics and inhibitors was used to evaluate their effects on the expression of candidate targets and functions. Immunohistochemistry and in situhybridisation were used to detect the expression of selected miRNAs and their targets in IM tissue microarrays. RESULTS: We demonstrate a bile acids-triggered pathway involving upregulation of miR-92a-1-5p and suppression of its target FOXD1 in gastric cells. We first found that miR-92a-1-5p was increased in IM tissues and induced by bile acids. Moreover, miR-92a-1-5p was found to activate CDX2 and downstream intestinal markers by targeting FOXD1/FOXJ1 axis and modulating activation of nuclear factor kappa B (NF-κB) pathway. Furthermore, these effects were found to be clinical relevant, as high miR-92a-1-5p levels were correlated with low FOXD1 levels and high CDX2 levels in IM tissues. CONCLUSION: These findings suggest a miR-92a-1-5p/FOXD1/NF-κB/CDX2 regulatory axis plays key roles in the generation of IM phenotype from gastric cells. Suppression of miR-92a-1-5p and restoration of FOXD1 may be a preventive approach for gastric IM in patients with bile regurgitation.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Li T, Guo H, Li H, et al. MicroRNA-92a-1-5p increases CDX2 by targeting FOXD1 in bile acids-induced gastric intestinal metaplasia. Gut. 2019. PMID: 30635407. doi:10.1136/gutjnl-2017-315318

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。